Product catalog antigen listed by alphabetic starting with F
| Items 301 to 400 of 808 total | 9 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| AR00060PU-N | Fibrinogen antigen | ||||||
| Mouse | Purified | Plasma | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00061PU-N | Fibrinogen antigen | ||||||
| Human | Purified | Plasma | 2 mg / US$ 305 | ||||
| Acris Antibodies GmbH | |||||||
| BA226 | Fibrinogen (plasmin + plasminogen free) antigen | ||||||
| Human | >90% | Serum | 25 mg / US$ 295 | ||||
| Acris Antibodies GmbH | |||||||
| H00002243-P01-10 | Fibrinogen alpha chain / FGA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002243-P01-25 | Fibrinogen alpha chain / FGA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 8FP1 | Fibrinogen alpha chain / FGA antigen | ||||||
| Human | Purified | - | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| H00002244-Q01-10 | Fibrinogen beta chain / FGB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002244-Q01-25 | Fibrinogen beta chain / FGB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA220 | Fibrinogen Degradation Product D (D-Dimer) antigen | ||||||
| Human | >95% | Plasma | 0.2 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BA221 | Fibrinogen Degradation Product D (D-Monomer) antigen | ||||||
| Human | >95% | Plasma | 0.2 mg / US$ 455 | ||||
| Acris Antibodies GmbH | |||||||
| 8D70 | Fibrinogen Degradation Product D (D-Dimer) antigen | ||||||
| Human | >95% | Plasma | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| H00002266-Q01-10 | Fibrinogen gamma chain / FGG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002266-Q01-25 | Fibrinogen gamma chain / FGG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002255-Q01-10 | Fibroblast growth factor 10 (FGF10) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002255-Q01-25 | Fibroblast growth factor 10 (FGF10) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA146 | Fibroblast growth factor 10 (FGF10) antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA146X | Fibroblast growth factor 10 (FGF10) antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00002256-Q01-10 | Fibroblast growth factor 11 / FGF11 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002256-Q01-25 | Fibroblast growth factor 11 / FGF11 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002257-P01-10 | Fibroblast growth factor 12 / FGF12 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002257-P01-25 | Fibroblast growth factor 12 / FGF12 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002258-P01-10 | Fibroblast growth factor 13 / FGF13 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002258-P01-25 | Fibroblast growth factor 13 / FGF13 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002259-Q01-10 | Fibroblast growth factor 14 / FGF14 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002259-Q01-25 | Fibroblast growth factor 14 / FGF14 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA147 | Fibroblast growth factor 16 / FGF16 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA147X | Fibroblast growth factor 16 / FGF16 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00008822-Q01-10 | Fibroblast growth factor 17 / FGF17 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008822-Q01-25 | Fibroblast growth factor 17 / FGF17 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA148 | Fibroblast growth factor 17 / FGF17 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA148X | Fibroblast growth factor 17 / FGF17 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00008817-P01-10 | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008817-P01-25 | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA149 | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA149X | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| 10-288-22378F | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | Purified | 90% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22378F-50 | Fibroblast growth factor 18 / FGF18 antigen | ||||||
| Human | Purified | 90% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| PA188 | Fibroblast growth factor 19 / FGF19 antigen | ||||||
| Human | Purified | >95% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA188X | Fibroblast growth factor 19 / FGF19 antigen | ||||||
| Human | Purified | >95% | E. coli | 25 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| PA223 | Fibroblast Growth Factor 20 / FGF20 antigen | ||||||
| Human | >95% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA223X | Fibroblast Growth Factor 20 / FGF20 antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00026291-P01-10 | Fibroblast growth factor 21 / FGF21 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026291-P01-25 | Fibroblast growth factor 21 / FGF21 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR01013PU-N | Fibroblast growth factor 21 / FGF21 antigen | ||||||
| Human | Purified | >90% | E. coli | 25 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| AR01013PU-S | Fibroblast growth factor 21 / FGF21 antigen | ||||||
| Human | Purified | >90% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA142 | Fibroblast growth factor 4 / FGF4 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA142X | Fibroblast growth factor 4 / FGF4 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA166 | Fibroblast growth factor 5 / FGF5 antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA166X | Fibroblast growth factor 5 / FGF5 antigen | ||||||
| Human | >95% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA143 | Fibroblast Growth Factor 6 / FGF6 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA143X | Fibroblast Growth Factor 6 / FGF6 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA093 | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| Human | >96% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA093X | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| Human | >96% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| GTX29601 | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| 10 µg / --- | |||||||
| GeneTex Inc. | |||||||
| 45102 | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| Rat | Purified | >90% | E. coli | 20 µg / --- | |||
| QED Bioscience Inc. | |||||||
| 45106P-10 | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| Human | >97% | E. coli | 10 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| 45106P-2 | Fibroblast growth factor 7 / FGF7 antigen | ||||||
| Human | >97% | E. coli | 2 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| PA144 | Fibroblast growth factor 8 / FGF8 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA144X | Fibroblast growth factor 8 / FGF8 antigen | ||||||
| Human | >95% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PR15004-25 | Fibroblast Growth Factor 8b / FGF8b antigen | ||||||
| Mouse | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15004CF-25 | Fibroblast Growth Factor 8b / FGF8b Carrier Free antigen | ||||||
| Mouse | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15017-25 | Fibroblast Growth Factor 8c / FGF8c antigen | ||||||
| Mouse | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15017CF-25 | Fibroblast Growth Factor 8c / FGF8c (Carrier-Free) antigen | ||||||
| Mouse | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| H00002254-Q01-10 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002254-Q01-25 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3504 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | Purified | >95% | Insect cells | 5 µg / US$ 235 | |||
| Acris Antibodies GmbH | |||||||
| DA3504X | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | Purified | >95% | Insect cells | 20 µg / US$ 345 | |||
| Acris Antibodies GmbH | |||||||
| PA004 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Mouse | >95% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA004X | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Mouse | >95% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA145 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | >95% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA145X | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Human | >95% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| GTX29745 | Fibroblast growth factor 9 / FGF9 antigen | ||||||
| Purified | 10 µg / --- | ||||||
| GeneTex Inc. | |||||||
| H00002246-Q01-10 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002246-Q01-25 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA054 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA054X | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | >95% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA1014 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | Purified | >95% | Insect cells | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1014X | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | Purified | >95% | Insect cells | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1014XC | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | Purified | >95% | Insect cells | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| GTX29592 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| 45101 | Fibroblast Growth Factor acidic / FGF1 antigen | ||||||
| Human | Purified | >90% | E. coli | 20 µg / --- | |||
| QED Bioscience Inc. | |||||||
| H00002247-Q01-10 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002247-Q01-25 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3503 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / US$ 235 | |||
| Acris Antibodies GmbH | |||||||
| DA3503X | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | E. coli | 25 µg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| DA3503XC | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | E. coli | 50 µg / US$ 335 | |||
| Acris Antibodies GmbH | |||||||
| PA055 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA055X | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | >95% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA1015 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | Insect cells | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1015X | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | Insect cells | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1015XC | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Human | Purified | >95% | Insect cells | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1017 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Bovine | Purified | >98% | E. coli | 10 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1017X | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Bovine | Purified | >98% | E. coli | 50 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1017XC | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| Bovine | Purified | >98% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| GTX29596 | Fibroblast Growth Factor basic / FGF2 antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| PR15002-25 | Fibroblast Growth Factor basic / FGF2 146 aa antigen | ||||||
| Human | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15002CF-25 | Fibroblast Growth Factor basic / FGF2 146 aa, Carrier Free antigen | ||||||
| Human | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15003-25 | Fibroblast Growth Factor basic / FGF2 157 aa antigen | ||||||
| Human | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15003CF-25 | Fibroblast Growth Factor basic / FGF2 157 aa, Carrier Free antigen | ||||||
| Human | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| DA3527 | Fibroblast Growth Factor Receptor 2 (FGFR-2/IIIC - Fc Chimera) (IIIC - Fc Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 10 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| DA3527X | Fibroblast Growth Factor Receptor 2 (FGFR-2/IIIC - Fc Chimera) (IIIC - Fc Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 50 µg / US$ 405 | |||
| Acris Antibodies GmbH | |||||||
| Items 301 to 400 of 808 total | 9 Page(s): |
